SBL
BMY icon

Sargent Bickham Lagudis’s Bristol-Myers Squibb BMY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.44M Sell
33,843
-1,024
-3% -$73.7K 0.2% 95
2022
Q3
$2.48M Sell
34,867
-2,487
-7% -$177K 0.22% 89
2022
Q2
$2.88M Buy
37,354
+2,527
+7% +$195K 0.25% 93
2022
Q1
$2.54M Sell
34,827
-9,464
-21% -$691K 0.2% 96
2021
Q4
$2.76M Sell
44,291
-25,027
-36% -$1.56M 0.21% 93
2021
Q3
$4.1M Buy
69,318
+982
+1% +$58.1K 0.33% 67
2021
Q2
$4.57M Buy
68,336
+2,140
+3% +$143K 0.37% 60
2021
Q1
$4.18M Buy
66,196
+4,346
+7% +$274K 0.37% 61
2020
Q4
$3.84M Buy
61,850
+1,280
+2% +$79.4K 0.35% 64
2020
Q3
$3.65M Buy
60,570
+5,379
+10% +$324K 0.37% 60
2020
Q2
$3.25M Buy
55,191
+36,563
+196% +$2.15M 0.35% 65
2020
Q1
$1.04M Sell
18,628
-787
-4% -$43.9K 0.13% 114
2019
Q4
$1.25M Buy
19,415
+1,194
+7% +$76.6K 0.14% 109
2019
Q3
$924K Buy
18,221
+125
+0.7% +$6.34K 0.11% 115
2019
Q2
$821K Buy
18,096
+3
+0% +$136 0.1% 122
2019
Q1
$863K Sell
18,093
-191
-1% -$9.11K 0.1% 125
2018
Q4
$950K Buy
18,284
+278
+2% +$14.4K 0.12% 112
2018
Q3
$1.12M Sell
18,006
-570
-3% -$35.4K 0.13% 113
2018
Q2
$1.03M Sell
18,576
-795
-4% -$44K 0.13% 113
2018
Q1
$1.23M Sell
19,371
-325
-2% -$20.6K 0.15% 100
2017
Q4
$1.21M Buy
19,696
+564
+3% +$34.6K 0.14% 115
2017
Q3
$1.22M Buy
19,132
+316
+2% +$20.1K 0.15% 116
2017
Q2
$1.05M Sell
18,816
-116
-0.6% -$6.46K 0.13% 118
2017
Q1
$1.03M Sell
18,932
-1,484
-7% -$80.7K 0.13% 122
2016
Q4
$1.19M Sell
20,416
-614
-3% -$35.9K 0.18% 109
2016
Q3
$1.13K Sell
21,030
-494
-2% -$27 0.17% 108
2016
Q2
$1.58M Sell
21,524
-361
-2% -$26.6K 0.25% 93
2016
Q1
$1.4M Buy
+21,885
New +$1.4M 0.23% 96